•
Mar 31, 2018

Denali Therapeutics Q1 2018 Earnings Report

Total Revenue
$641K
EPS
-$0.26
Previous year: -$2.36
-89.0%
Gross Profit
-$20.2M
Previous year: -$18.5M
+9.2%
Cash and Equivalents
$44M
Free Cash Flow
$33M
Total Assets
$614M

Denali Therapeutics

Denali Therapeutics